Ceftriaxone And Dextrose (ceftriaxone) NDC 0264-3153

NDC codes

FDA NDC Directory

Product NDC (as listed)0264-3153Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00264-3153Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0264-3153-11	00264315311	24 CONTAINER in 1 CASE (0264-3153-11) / 50 mL in 1 CONTAINERMarketed from Apr 20, 2005

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Ceftriaxone And Dextrose
Generic name (nonproprietary): ceftriaxone
Active ingredients: Ceftriaxone sodium — 1 g/50mL
Dosage form: Injection, Solution
Route: Intravenous
Labeler: B. Braun Medical Inc.
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 050796
Marketing start: Apr 20, 2005
Listing expires: Dec 31, 2026
Other FDA classes: Cephalosporins (Chemical structure)
Identifiers: Product ID 0264-3153_05bf8d04-202d-472f-94b5-4f5d9020f0c7SPL ID 05bf8d04-202d-472f-94b5-4f5d9020f0c7SPL set ID 67153914-16bc-490d-82d7-638061618467RxCUI 1665021, 1665046UNII 023Z5BR09K
Pharmacologic class: Cephalosporin Antibacterial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeMed-Code curated

J0696 — Injection, ceftriaxone sodium, per 250 mg

Billing unit: 250 mg. Units on the claim = dose given ÷ 250 mg.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N400264315311 followed by a unit qualifier and the quantity

Package 00264-3153-11. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 13, 2022.

Indications (excerpt from the label)

Ceftriaxone for Injection and Dextrose Injection is indicated for the treatment of the following infections when caused by susceptible bacteria. Ceftriaxone for Injection and Dextrose Injection is a cephalosporin antibacterial indicated for the treatment of the following infections caused by susceptible isolates of the designated bacteria: Lower Respiratory Tract Infections ( 1.1 ); Skin and Skin Structure Infections ( 1.2 ); Complicated and Uncomplicated Urinary Tract Infections ( 1.3 ); Pelvic Inflammatory Disease ( 1.4 ); Bacterial Septicemia ( 1.5 ); Bone and Joint Infections ( 1.6 ); Intra-abdominal Infections ( 1.7 ); Meningitis ( 1.8 ); and Surgical Prophylaxis ( 1.9 ). To reduce the …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 050796

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 050796
Product	Strength	Form · route	Labeler	Product NDC
Ceftriaxone And Dextroseceftriaxone	Ceftriaxone sodium 2 g/50mL	Injection, SolutionIntravenous	B. Braun Medical Inc.	0264-3155